Bredt David (CIK 0002022087)

Latest company ownership

RAPP - Rapport Therapeutics, Inc.
Role: Chief Scientific Officer
Shares held
401,142
Last filed at
Nov 18, 2025
Confidence Score
29.5
2025Q4
Confidence Score History
2025Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 15, 2025 Dec 16, 2025 Rapport Therapeutics, Inc. Chief Scientific Officer Sell 38.8 -8,500 -2.12% ✓ $255.1K
Nov 17, 2025 Nov 18, 2025 Rapport Therapeutics, Inc. Chief Scientific Officer Sell 41.3 -8,500 -2.07% ✓ $214.1K
Oct 15, 2025 Oct 16, 2025 Rapport Therapeutics, Inc. Chief Scientific Officer Sell 41.3 -8,500 -2.03% ✓ $219.2K
Sep 15, 2025 Sep 17, 2025 Rapport Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -8,500 -1.99% ✓ $205.6K
Aug 15, 2025 Aug 18, 2025 Rapport Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -8,500 -1.95% ✓ $127.5K
Jul 15, 2025 Jul 16, 2025 Rapport Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -8,500 -1.92% ✓ $119K
Jun 16, 2025 Jun 18, 2025 Rapport Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -8,500 -1.88% ✓ $93.5K
May 15, 2025 May 19, 2025 Rapport Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -8,500 -1.85% ✓ $81.3K
Apr 15, 2025 Apr 16, 2025 Rapport Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -8,500 -1.81% ✓ $81.3K
Mar 14, 2025 Mar 17, 2025 Rapport Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -8,500 -1.78% ✓ $92.2K